Drug intelligence / Profile preview

White Widow

Development stage
Unknown
Lead developer
Green House Seed Co.
Modality
Small Molecules
Administration
Inhalation, Oral
01

Overview

White Widow is a prominent hybrid cannabis strain, characterized by its Sativa-dominant profile and high resin production. Originally bred in the Netherlands by Green House Seeds in the early 1990s, it is a genetic cross between a Brazilian Sativa landrace and a resin-heavy South Indian Indica hybrid. The strain's pharmacological profile is defined by a high concentration of delta-9-tetrahydrocannabinol (THC) and a diverse terpene profile, including myrcene, caryophyllene, and limonene. Its primary mechanism of action involves the partial agonism of the Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2) within the endocannabinoid system. CB1 activation in the central nervous system mediates its psychoactive and analgesic effects, while CB2 activation contributes to its anti-inflammatory properties. White Widow is frequently utilized in medical cannabis programs for the management of chronic pain, anxiety, stress, and insomnia, offering a balance of cerebral stimulation and physical relaxation.

Brand names
White Widow
02

Targets

CNR1 (Cannabinoid receptor 1)MMP12 (Macrophage Metalloelastase)GPR55 (G protein-coupled receptor 55)KRAS (Kirsten rat sarcoma viral oncogene homolog)HCK (Haematopoietic Cell Kinase)GPR18 (G protein-coupled receptor 18)

Beyond the preview

Go deeper on White Widow.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on White Widow.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call